Drug Shortage Report for MAXITROL
Report ID | 172560 |
Drug Identification Number | 00042676 |
Brand name | MAXITROL |
Common or Proper name | MAXITROL SUSPENSION |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | POLYMYXIN B SULFATE NEOMYCIN DEXAMETHASONE |
Strength(s) | 6000UNIT 3.5MG 0.1% |
Dosage form(s) | SUSPENSION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 5ML |
ATC code | S01CA |
ATC description | ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2022-11-09 |
Actual start date | |
Estimated end date | 2022-12-02 |
Actual end date | 2023-01-13 |
Shortage status | Resolved |
Updated date | 2023-01-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-10-25 | English | Compare |
v2 | 2022-10-25 | French | Compare |
v3 | 2022-11-10 | English | Compare |
v4 | 2023-01-25 | English | Compare |
v5 | 2023-01-25 | French | Compare |
Showing 1 to 5 of 5